Literature DB >> 20688203

Optical advances in skeletal imaging applied to bone metastases.

T J A Snoeks1, A Khmelinskii, B P F Lelieveldt, E L Kaijzel, C W G M Löwik.   

Abstract

Optical Imaging has evolved into one of the standard molecular imaging modalities used in pre-clinical cancer research. Bone research however, strongly depends on other imaging modalities such as SPECT, PET, x-ray and μCT. Each imaging modality has its own specific strengths and weaknesses concerning spatial resolution, sensitivity and the possibility to quantify the signal. An increasing number of bone specific optical imaging models and probes have been developed over the past years. This review gives an overview of optical imaging modalities, models and probes that can be used to study skeletal complications of cancer in small laboratory animals.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20688203     DOI: 10.1016/j.bone.2010.07.027

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  10 in total

Review 1.  Imaging of bone metastasis: An update.

Authors:  Gerard J O'Sullivan; Fiona L Carty; Carmel G Cronin
Journal:  World J Radiol       Date:  2015-08-28

2.  Hands-free, wireless goggles for near-infrared fluorescence and real-time image-guided surgery.

Authors:  Yang Liu; Adam Q Bauer; Walter J Akers; Gail Sudlow; Kexian Liang; Duanwen Shen; Mikhail Y Berezin; Joseph P Culver; Samuel Achilefu
Journal:  Surgery       Date:  2011-05       Impact factor: 3.982

3.  CT-based handling and analysis of preclinical multimodality imaging data of bone metastases.

Authors:  Thomas J A Snoeks; Martin Baiker; Eric L Kaijzel; Boudewijn P F Lelieveldt; Clemens W G M Löwik
Journal:  Bonekey Rep       Date:  2012-05-09

Review 4.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

5.  Combined in vivo optical and µCT imaging to monitor infection, inflammation, and bone anatomy in an orthopaedic implant infection in mice.

Authors:  Nicholas M Bernthal; Brad N Taylor; Jeffrey A Meganck; Yu Wang; Jonathan H Shahbazian; Jared A Niska; Kevin P Francis; Lloyd S Miller
Journal:  J Vis Exp       Date:  2014-10-16       Impact factor: 1.355

6.  Imaging technologies for preclinical models of bone and joint disorders.

Authors:  Jordi L Tremoleda; Magdy Khalil; Luke L Gompels; Marzena Wylezinska-Arridge; Tonia Vincent; Willy Gsell
Journal:  EJNMMI Res       Date:  2011-07-29       Impact factor: 3.138

7.  Photothermal tomography for the functional and structural evaluation, and early mineral loss monitoring in bones.

Authors:  Sreekumar Kaiplavil; Andreas Mandelis; Xueding Wang; Ting Feng
Journal:  Biomed Opt Express       Date:  2014-07-07       Impact factor: 3.732

8.  Interactive local super-resolution reconstruction of whole-body MRI mouse data: a pilot study with applications to bone and kidney metastases.

Authors:  Oleh Dzyubachyk; Artem Khmelinskii; Esben Plenge; Peter Kok; Thomas J A Snoeks; Dirk H J Poot; Clemens W G M Löwik; Charl P Botha; Wiro J Niessen; Louise van der Weerd; Erik Meijering; Boudewijn P F Lelieveldt
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

9.  Monitoring bacterial burden, inflammation and bone damage longitudinally using optical and μCT imaging in an orthopaedic implant infection in mice.

Authors:  Jared A Niska; Jeffrey A Meganck; Jonathan R Pribaz; Jonathan H Shahbazian; Ed Lim; Ning Zhang; Brad W Rice; Ali Akin; Romela Irene Ramos; Nicholas M Bernthal; Kevin P Francis; Lloyd S Miller
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

Review 10.  Multimodal imaging of bone metastases: From preclinical to clinical applications.

Authors:  Stephan Ellmann; Michael Beck; Torsten Kuwert; Michael Uder; Tobias Bäuerle
Journal:  J Orthop Translat       Date:  2015-08-13       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.